Purple Biotech (PPBT) Other financing activities (2017 - 2022)

Purple Biotech (PPBT) has 5 years of Other financing activities data on file, last reported at $8.0 million in Q4 2022.

• On a quarterly basis, Other financing activities rose 25.06% year-over-year to $8.0 million in Q4 2022; TTM through Dec 2022 was $32.2 million, a 323.84% increase from a year earlier, with the FY2022 full-year figure at $19.8 million, up 1551.5% from the prior year.
• Other financing activities for Q4 2022 stood at $8.0 million, down from $17.8 million in the prior quarter.
• Over the last five years, Other financing activities for PPBT reached as high as $17.8 million in Q1 2022 and fell as low as $1.2 million in Q1 2021.
• Historically, Other financing activities has averaged $7.3 million across 4 years, with a median of $6.0 million in 2020.
• Across the five-year window, Other financing activities climbed 12.29% in 2020 and surged 1383.33% in 2022, its largest moves.
• Year by year, Other financing activities stood at $5.0 million in 2019, then increased by 12.29% to $5.6 million in 2020, then grew by 13.67% to $6.4 million in 2021, then rose by 25.06% to $8.0 million in 2022.
• Per Business Quant data, the three most recent Other financing activities figures were $8.0 million in Q4 2022, $17.8 million in Q1 2022, and $6.4 million in Q4 2021.